ID: ALA5284825

Max Phase: Preclinical

Molecular Formula: C38H36ClN7O8S

Molecular Weight: 786.27

Associated Items:

Representations

Canonical SMILES:  Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)OCC(=O)NCCCCOc1cccc3c1C(=O)N(C1CCC(=O)NC1=O)C3=O)c1nnc(C)n1-2

Standard InChI:  InChI=1S/C38H36ClN7O8S/c1-19-20(2)55-38-31(19)33(22-9-11-23(39)12-10-22)41-25(34-44-43-21(3)45(34)38)17-30(49)54-18-29(48)40-15-4-5-16-53-27-8-6-7-24-32(27)37(52)46(36(24)51)26-13-14-28(47)42-35(26)50/h6-12,25-26H,4-5,13-18H2,1-3H3,(H,40,48)(H,42,47,50)/t25-,26?/m0/s1

Standard InChI Key:  PLVCAPPHMNXCHP-PMCHYTPCSA-N

Associated Targets(Human)

von Hippel-Lindau disease tumor suppressor/Bromodomain-containing protein 4 105 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 786.27Molecular Weight (Monoisotopic): 785.2035AlogP: 4.11#Rotatable Bonds: 12
Polar Surface Area: 191.25Molecular Species: NEUTRALHBA: 13HBD: 2
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.59CX Basic pKa: 4.21CX LogP: 3.36CX LogD: 3.36
Aromatic Rings: 4Heavy Atoms: 55QED Weighted: 0.12Np Likeness Score: -0.93

References

1. Bhela IP, Ranza A, Balestrero FC, Serafini M, Aprile S, Di Martino RMC, Condorelli F, Pirali T..  (2022)  A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs.,  65  (22.0): [PMID:36323630] [10.1021/acs.jmedchem.2c01218]

Source